Product description

Children’s Panadol Baby Drops Syringe dosing device provided with Children's Panadol 1 month to 2 years

See a list of details to help identify the product

Reason the product is recalled

The syringe may display incorrect dosage indicators.

The hazards to consumers

If the incorrect dosage is given to a child it may result in illness.

What consumers should do

Consumers should check syringes to determine whether they are affected. If you are uncertain whether your syringe is affected, please consult your pharmacist. If the syringe is incorrect, it should be returned to the pharmacy or call the GSK Product Information line on 1800 650 123.

If you have any concerns that your child may have received too much Children’s Panadol®, or if an overdose is taken or suspected, ring the Poisons Information Centre (Australia131 126) or go to the hospital immediately, even if your child feels well. There is a risk of delayed, serious liver damage if left untreated.

Details to help identify the product

Supplier running the recall

GlaxoSmithKline Australia Pty Ltd

Who sold the product

Various pharmacies nationwide

Identifying product features

All batches may potentially be affected

Identifying numbers

Other identifying numbers

All batches may potentially be affected

Where the product was sold

Nationally

Responsible regulators

Regulators are established or appointed by government. They enforce regulations and rules.

Quote PRA number 2013/13868 when contacting a regulator about this recall.

Recall and remedy questions

Contact the Therapeutic Goods Administration if you have:

  • a question about the remedy being offered to you by the business that is responsible for managing this recall, or
  • concerns about the way the business is managing this recall.